Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanol SCHEMBL28196236 | 0.98 | LMNA (0.54) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| Butyl Alcohol SCHEMBL4615954 | 0.93 | ALDH1A1 (0.50) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| Hexane SCHEMBL21617124 | 0.89 | CYP1A2 (0.45) | ALDH1A1TSHRNAAACYP1A2DUSP3 | |
| Heptane SCHEMBL28220275 | 0.86 | NAAA (0.44) | TSHRNAAACYP1A2DUSP3 | |
| Propanol SCHEMBL4616364 | 0.86 | NAAA (0.32) | LMNAALDH1A1TSHRNAAACYP1A2 | |
| SCHEMBL16339695 | 0.78 | TSHR (0.50) | ALDH1A1TSHRNAAACYP1A2DUSP3 | |
| 1-Pentanol SCHEMBL27509755 | 0.76 | SMN1; SMN2 (0.71) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| 1-Pentanol SCHEMBL8751522 | 0.76 | — | — | |
| Butylamine SCHEMBL10776959 | 0.76 | DNM1 (0.40) | ALDH1A1MEN1KMT2ATSHRNAAA | |
| Propane SCHEMBL27666583 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108715723-B | Electrocoating compositions containing anticrater agent | 涂层国外知识产权有限公司 | 2021-11-02 | — | — | CN | disclosed |
| US-10577510-B2 | Electrocoating composition including an anti-crater agent | Axalta Coating Systems IP Co. LLC (US) | 2020-03-03 | — | — | US | disclosed |
| CN-108715723-A | Include the Electrocoat composition of anticrater agent | 涂层国外知识产权有限公司 | 2018-10-30 | — | — | CN | disclosed |
| US-20180282557-A1 | ELECTROCOATING COMPOSITON INCLUDING AN ANTI-CRATER AGENT | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2018-10-04 | — | — | US | disclosed |
| EP-1819782-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING AN ANTI-CRATER AGENT | DU PONT (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1831317-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING AN ANTI-CRATER AGENT | DU PONT (US) | 2008-03-05 | — | — | EP | disclosed |
| US-7264706-B2 | Cathodic electrocoating compositions containing an anti-crater agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7264705-B2 | Cathodic electrocoating compositions containing an anti-crater agent | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20060084725-A1 | Cathodic electrocoating compositions containing an anti-crater agent | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2006-04-20 | — | — | US | disclosed |
| US-20060084726-A1 | Cathodic electrocoating compositions containing an anti-crater agent | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2006-04-20 | — | — | US | disclosed |
| EP-1425354-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING HYDROXYL-CARBONATE BLOCKED POLYISOCYANATE CROSSLINKING AGENT | DU PONT (US) | 2005-03-16 | — | — | EP | disclosed |
| US-6825361-B2 | EPOXY-AMINE ADDUCTS; ELECTRODEPOSITED FINISHES WITH REDUCED WEIGHT LOSS WHEN HEATED TO CURE | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-11-30 | — | — | US | disclosed |
| US-20040084313-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | PALADIN PHARMA INC. (CA) | 2004-05-06 | — | — | US | disclosed |
| US-6607646-B2 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-08-19 | — | — | US | disclosed |
| US-20030064227-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064227-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | TET2, TET1, HAAO | SMN1; SMN2 4794/4885LMNA 1591/4885ALDH1A1 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.